News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

35,144 signal articles · 107 in last 24h · 178,660 total before filter · latest 1h ago

107last 24h

3127last 7d

512● bullish (7d)

311● bearish (7d)

227publishers

All Macro103 Earnings1821 M&A172 Regulatory23 Product26 Analyst28

✕ clear all filtersticker: RXRXSentiment:bullish neutral bearish show all (incl. clickbait)

Simply Wall St.3d agoneutral

Is Recursion Pharmaceuticals (RXRX) A Bargain After Q3 Earnings And Clinical Updates?

RXRX

Zacks4d agoneutral

RXRX Q3 Earnings Call Highlights Clinical Progress and Cash Runway

RXRX

Moby5d agoneutral

Recursion Pharmaceuticals, Inc. Q3 2026 Earnings Call Summary

NVDA RXRX

Motley Fool5d agoneutral

Recursion (RXRX) Q3 2026 Earnings Call Transcript

RXRX

MarketBeat5d agoneutral

What Recursion Pharmaceuticals (RXRX) Said on Its Q3 Earnings Call

RXRX

Zacks5d agobullish

Recursion's Q3 Earnings Beat Estimates on Sanofi Milestone Revenues

IOVA RXRX

Associated Press5d agoneutral

Recursion Pharmaceuticals: Q3 Earnings Snapshot

RXRX

Zacks6d agobullish

Recursion Pharmaceuticals (RXRX) Reports Q3 Loss, Tops Revenue Estimates

RXRX

GuruFocus.com6d agoneutral

Earnings To Watch: Recursion Pharmaceuticals Inc (RXRX) Q3 2026 -- GF Value Sees 33% Downside

RXRX

GuruFocus.com9d agoneutral

Earnings To Watch: Recursion Pharmaceuticals Inc (RXRX) Q3 2026 -- GF Value Sees 35% Downside

RXRX

Zacks10d agoneutral

Recursion Pharmaceuticals to Report Q3 Earnings: What's in the Cards?

RXRX

Zacks11d agobullish

Recursion Pharmaceuticals (RXRX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

RXRX

Zacks65d agoneutral

Why Is Recursion Pharmaceuticals (RXRX) Up 8.2% Since Last Earnings Report?

MRNA RXRX

Motley Fool88d agoneutral

Recursion (RXRX) Q2 2026 Earnings Call Transcript

RXRX

Moby95d agoneutral

Recursion Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary

RXRX

MarketBeat95d agoneutral

Recursion Pharmaceuticals Q2 Earnings Call Highlights

RXRX

Zacks95d agobearish

Recursion Pharmaceuticals (RXRX) Reports Q2 Loss, Misses Revenue Estimates

RXRX

Zacks156d agoneutral

Recursion Pharmaceuticals (RXRX) Up 16.2% Since Last Earnings Report: Can It Continue?

RXRX

Motley Fool185d agoneutral

Recursion (RXRX) Q1 2026 Earnings Transcript

RXRX

MarketBeat186d agoneutral

Recursion Pharmaceuticals Q1 Earnings Call Highlights

RXRX

Zacks186d agoneutral

Recursion Pharmaceuticals (RXRX) Reports Q1 Loss, Lags Revenue Estimates

RXRX